Latest news
FAST taps Apertura's BBB-crossing AAV platform to advance Angelman gene therapy - AllSciAllSci · Thu, 06 Aug 2026 08:01:27 GMTFoundation for Angelman Syndrome Therapeutics Announces Agreement with Apertura Gene Therapy for Access to Blood-Brain Barrier-Crossing Capsid - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTMom Reveals How She Financially Supports Family with 4 Kids with Disabilities (Exclusive) - People.comPeople.com · Wed, 05 Aug 2026 10:00:00 GMTAngelman Syndrome Foundation and Citizen Health Partner to Put Advanced AI to Work for Every Angelman Family - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTOak Hill Bio Announces Dosing of First Participant in - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 12:00:00 GMTRA Capital launches Oak Hill Bio onto the Nasdaq via SPAC - Fierce BiotechFierce Biotech · Mon, 27 Jul 2026 19:25:29 GMTOak Hill Bio and Research Alliance Corporation III Announce - GlobeNewswireGlobeNewswire · Mon, 27 Jul 2026 12:00:00 GMTRA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease - STATSTAT · Mon, 27 Jul 2026 07:00:00 GMT